| Marcelin AG, Flandre P, Descamps D, et al.
Factors associated with virological response to etravirine in non nucleoside reverse transcriptase inhibitor experienced HIV-1 infected patients. [JOURNAL ARTICLE]
Antimicrob Agents Chemother 2009 Nov 9.
Abstract | Full Citation | Find Related Articles | | Delelis O, Thierry S, Subra F, et al.
Impact of Y143 HIV-1 integrase mutations on resistance to Raltegravir in vitro and in vivo. [JOURNAL ARTICLE]
Antimicrob Agents Chemother 2009 Nov 9.
Abstract | Full Citation | Find Related Articles | | Quaranta S, Woloch C, Paccou A, et al.
Validation of an Electrospray Ionization LC-MS/MS Method for Quantitative Analysis of Raltegravir, Etravirine, and 9 Other Antiretroviral Agents in Human Plasma Samples. [JOURNAL ARTICLE]
Ther Drug Monit 2009 Oct 27.
Abstract | Full Citation | Find Related Articles | | Shimura K, Kodama EN
Elvitegravir: a new HIV integrase inhibitor. [Journal Article]
Antivir Chem Chemother 2009; 20(2):79-85.
Abstract | Full Citation | Find Related Articles | | Scherrer AU, von Wyl V, Fux CA, et al.
Implementation of Raltegravir in Routine Clinical Practice: Selection Criteria for Choosing This Drug, Virologic Response Rates, and Characteristics of Failures. [JOURNAL ARTICLE]
J Acquir Immune Defic Syndr 2009 Oct 16.
Abstract | Full Citation | | Thuret I, Chaix ML, Tamalet C, et al.
Raltegravir, etravirine and r-darunavir combination in adolescents with multidrug-resistant virus. [Journal Article, Research Support, Non-U.S. Gov't]
AIDS 2009 Nov 13; 23(17):2364-6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Grant PM, Palmer S, Bendavid E, et al.
Switch from enfuvirtide to raltegravir in virologically suppressed HIV-1 infected patients: Effects on level of residual viremia and quality of life. [JOURNAL ARTICLE]
J Clin Virol 2009 Oct 8.
Abstract | Full Citation | | Yazdanpanah Y, Fagard C, Descamps D, et al.
High Rate of Virologic Suppression with Raltegravir Plus Etravirine and Darunavir/Ritonavir among Treatment-Experienced Patients Infected with Multidrug-Resistant HIV: Results of the ANRS 139 TRIO Trial. [JOURNAL ARTICLE]
Clin Infect Dis 2009 Oct 8.
Abstract | Full Citation | | Buzón MJ, Dalmau J, Puertas MC, et al.
The HIV-1 integrase genotype strongly predicts raltegravir susceptibility but not viral fitness of primary virus isolates. [JOURNAL ARTICLE]
AIDS 2009 Sep 16.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Bogner JR
[Integrase inhibition] [Journal Article]
MMW Fortschr Med 2009 Apr 30; 151(18):68-71.
Full Citation |    |
|
| |
Advertise on this site.
|
